Vaccine Potentiation by Combination Adjuvants

Area of Science:

• Vaccinology and immunology, focusing on the role of adjuvants in vaccine development.

Background:

• Adjuvants are essential vaccine components that enhance immune responses and reduce antigen requirements.
• Modern vaccine formulations increasingly utilize combination adjuvants, which comprise multiple molecules acting synergistically.

Purpose of the Study:

• To review established and emerging combination adjuvants for human and animal vaccines.
• To summarize the performance of these adjuvants in preclinical and clinical studies.
• To highlight their potential in directing specific immune responses (Th1, Th2, Th17).

Main Methods:

• Review of licensed and developmental combination adjuvants, including ISCOMs, liposomes, Montanide Adjuvant Systems, and triple adjuvant combinations.
• Analysis of data from preclinical and clinical trials assessing adjuvant performance.

Main Results:

• Combination adjuvants demonstrate synergistic effects by activating diverse immune mechanisms.
• Several combination adjuvants have shown promise in promoting enhanced and balanced immune responses.
• These adjuvants are capable of directing immune responses towards desired profiles, such as Th1, Th2, or Th17 bias.

Conclusions:

• Combination adjuvants represent a significant advancement in vaccine technology, offering improved efficacy and tailored immune responses.
• The development of a diverse panel of combination adjuvants is crucial for addressing various disease targets and populations.
• Ongoing research and development in combination adjuvants hold substantial promise for future vaccine strategies.